BetterLife Pharma Inc. (NPAU.F)

0.0750 +0.0030 (+4.17%) As of 08:10AM CEST. Market open.

BetterLife Pharma Inc.

1275 West 6th Avenue
Suite 300
Vancouver, BC V6H 1A6
Canada

https://www.abetterlifepharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Ahmad Doroudian Ph.D.	Founder, CEO & Chairman	205.04k	N/A	1960
Ms. Moira Ong C.A., CPA, CA, CFA	Chief Financial Officer	180.44k	N/A	1975
Dr. Hooshmand Sheshbaradaran Ph.D.	Chief Operating Officer	249.04k	N/A	1957
Dr. Stephen Sangha	Corporate Development Advisor	N/A	N/A	N/A
Mr. Scott Rudge Ph.D.	Head of CMC	N/A	N/A	N/A
Anthony Calandra Ph.D.	Head of Regulatory	N/A	N/A	N/A
Dr. Abdi Ghaffari Ph.D.	Head of Preclinical & Toxicology	N/A	N/A	N/A

Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for the treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream that has completed Phase II clinical trials for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.

Corporate governance

BetterLife Pharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.